Persodia Insights provide curated analysis of the structural forces shaping the IVD industry. They move beyond reporting to examine recurring patterns, tensions and strategic questions with implications for diagnostics companies, healthcare systems and the wider market environment.
Insights may emerge from Observations, published research, market developments, regulatory change, capital dynamics or recurring industry questions. Their purpose is to develop greater structural clarity by connecting visible developments to the deeper forces that shape outcomes over time.
Explore Insights
Use the filters to explore the domains most relevant to your work. Each Insight examines how one or more structural constraints appear in practice and what they may mean for strategic judgement.
-
IVD Industry Monograph No. 4 – Beyond the Data Feed: Diagnostic Contribution in Health Intelligence
Health intelligence is reshaping how diagnostic information is used across healthcare, research and AI-enabled systems. This fourth Persodia IVD Industry Monograph examines how Diagnostics can contribute beyond producing results by…
-
IVD Industry Monograph No. 3 – Beyond Market Access – Foundations for Sustaining Europe’s IVD Leadership
Beyond Market Access – Foundations for Sustaining Europe’s IVD Leadership Europe’s diagnostics industry shows visible continuity but declining structural durability. IVD’s share of healthcare expenditure fell from 0.80% in 2009…
-
IVD Industry Monograph No. 2 – Earning Position: How Evidence Becomes Authority
Earning Position: How Evidence Becomes Authority Diagnostics fail not analytically but through Evidence Escape: evidence does not automatically become clinical authority. Seven evidence domains govern adoption—analytical, clinical, regulatory, economic, operational.…
-
IVD Industry Monograph No. 1 – Crossing from Analytical to Diagnostics: The Difficulty is the Moat
Crossing from Analytical to Diagnostics: The Difficulty is the Moat Most analytical technologies never reach clinical diagnostics—not due to inadequate performance, but because clinical markets demand structural transformation: from flexibility…
-
The Book – INSIGHT 6 – Health Intelligence Will Not Remove Constraint. It Will Densify It.
The next frontier is not more data. It is the ability to sustain trustworthy meaning across systems. Why does this matter now? Artificial intelligence is accelerating expectations across healthcare. Diagnostics…
-
The Book – INSIGHT 5 – Strategy in Diagnostics Is Selection Under Constraint.
The central question is not which opportunity appears most attractive. It is which exposure the organisation is prepared to inhabit. Why does this matter now? Diagnostics strategy is often presented…
Related Strategic Domains
Persodia organizes its research across ten strategic domains. Together, they provide a structured map of the forces shaping diagnostics companies, healthcare systems and the future of the industry.
Policy
Regulatory architecture shaping position
Innovation
Where competitive advantage emerges
Operations
Manufacturing, supply chains, resilience and execution.
Market Access
Approval converted to clinical adoption
Partnerships
Partnership asymmetry and collaboration
Market Data
Datasets, taxonomies and frameworks
Customers
Healthcare consolidation and procurement
Capital
Capital formation and financial durability
Commercialization
Channel strategy, market reach and scalable go-to-market models
Health Intelligence
Health Intelligence and AI diagnostics
Insights provide interpretation. The Foundation explains the deeper structural framework behind Persodia’s analysis.